Ionis Pharmaceuticals, Inc.
IONS
$32.96
$0.060.18%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 69.32% | -40.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 69.32% | -40.59% | |||
| Cost of Revenue | 12.90% | -2.39% | |||
| Gross Profit | 73.86% | -8,797.55% | |||
| SG&A Expenses | 42.90% | -5.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.45% | -3.04% | |||
| Operating Income | 25.45% | -124.93% | |||
| Income Before Tax | 25.72% | -117.67% | |||
| Income Tax Expenses | 25.71% | -5,757.81% | |||
| Earnings from Continuing Operations | 25.72% | -112.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.72% | -112.00% | |||
| EBIT | 25.45% | -124.93% | |||
| EBITDA | 25.78% | -131.22% | |||
| EPS Basic | 30.15% | -108.24% | |||
| Normalized Basic EPS | 32.24% | -127.28% | |||
| EPS Diluted | 30.15% | -108.24% | |||
| Normalized Diluted EPS | 32.24% | -127.28% | |||
| Average Basic Shares Outstanding | 6.33% | 1.81% | |||
| Average Diluted Shares Outstanding | 6.33% | 1.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
